# DDI1

## Overview
DDI1 is a gene that encodes the DNA damage inducible 1 homolog 1 protein, which is a crucial component of the ubiquitin-proteasome system. This protein is characterized by its multi-domain structure, including a ubiquitin-like (UBL) domain and a retroviral protease-like (RVP) domain, which facilitate its role in protein degradation and cellular homeostasis (Trempe2016Structural; Fabijan2024Domains). As a shuttle protein, DDI1 captures ubiquitinated substrates and delivers them to the proteasome, playing a significant role in regulating the cell cycle and responding to DNA damage (Fabijan2024Domains). The protein's involvement in the DNA damage response and its interactions with various cellular components underscore its importance in maintaining genomic stability and proper cell cycle progression (Voloshin2012Transfer; Fabijan2024Domains). Additionally, DDI1 has been implicated in clinical contexts, such as cancer and neurodegenerative diseases, due to its role in proteasome activity and genomic integrity (Lehrbach2016Proteasome).

## Structure
The human DDI1 protein is characterized by a multi-domain structure that includes a ubiquitin-like (UBL) domain and a retroviral protease-like (RVP) domain. The UBL domain, although sharing only 14% sequence identity with ubiquitin, maintains a typical ubiquitin fold, facilitating interactions with proteasomal components (Trempe2016Structural; Fabijan2024Domains). The RVP domain is homologous to retroviral aspartic proteases and is essential for the protein's function, forming dimers with a two-fold dyad symmetry. This domain includes a catalytic triad motif, similar to the aspartic protease family, and is involved in substrate interaction (Trempe2016Structural; Fabijan2024Domains).

The DDI1 protein also contains a helical domain (HDD), which shows structural similarity to DNA-binding domains, suggesting a potential role in DNA interaction (Trempe2016Structural). The protein's structure is dynamic, with the UBL and HDD domains showing variability in their positions relative to the RVP dimer (Trempe2016Structural). Human homologs of DDI1 lack the ubiquitin-associated (UBA) domain found in yeast, instead possessing a ubiquitin-interacting motif (UIM) for binding monoubiquitin (Fabijan2024Domains). The protein may undergo post-translational modifications, such as phosphorylation, although specific details are not provided in the context.

## Function
The DDI1 protein is a multifunctional component of the ubiquitin-proteasome system, primarily involved in protein degradation and turnover. It functions as a shuttle protein, capturing ubiquitinated substrates and delivering them to the proteasome for degradation, which is crucial for maintaining protein homeostasis and cellular proteostasis (Elu2019Detailed; Fabijan2024Domains). DDI1 contains a ubiquitin-like (UBL) domain and a ubiquitin-binding domain (UBD), facilitating its interaction with the proteasome and ubiquitin chains (Elu2019Detailed). 

In healthy human cells, DDI1 plays a role in regulating the cell cycle, particularly in the transition from the G2 phase to the M phase, and in the separation of sister chromatids during anaphase (Fabijan2024Domains). It also interacts with the SCF Ufo1 E3 ligase complex, influencing the degradation of G1 cyclins, which are essential for cell cycle progression and DNA synthesis (Fabijan2024Domains). 

DDI1 is involved in the DNA damage response, where it is transcriptionally induced in response to genotoxic stress, contributing to the repair of DNA-protein crosslinks and the degradation of stalled RNA polymerase II (Fabijan2024Domains). Its activity is crucial for maintaining genomic stability and ensuring proper cell cycle checkpoints.

## Clinical Significance
Mutations and alterations in the expression of the DDI1 gene have been implicated in various diseases and conditions. DDI1 is involved in the ubiquitin-proteasome system, which is crucial for protein degradation and cellular homeostasis. Disruptions in this system can lead to the accumulation of undegraded proteins, contributing to cellular stress and disease (Fabijan2024Domains).

In the context of cancer, DDI1 has been associated with resistance to proteasome inhibitors, which are used in cancer therapies. The activation of Nrf1, a transcription factor regulated by DDI1, promotes the survival of cancer cells treated with these inhibitors. Targeting DDI1 could potentially enhance the effectiveness of cancer treatments by overcoming drug resistance (Lehrbach2016Proteasome).

DDI1's role in DNA damage response and genomic integrity suggests its involvement in conditions related to genome instability, which can impact cancer progression. Its function in DNA-protein crosslink repair and response to replication stress highlights its importance in maintaining genomic stability (Fabijan2024Domains).

Alterations in DDI1 expression or function may also be relevant in neurodegenerative diseases, where proteasome activity is often dysregulated, leading to protein aggregation and cellular dysfunction (Lehrbach2016Proteasome).

## Interactions
The DDI1 protein in yeast, a homolog of the human DDI1, is involved in various protein interactions that are crucial for its function in cellular processes. DDI1 interacts with the SCF Ufo1 E3 ligase complex, where it facilitates the ubiquitination and degradation of the Ho endonuclease. This interaction is mediated through the UBL domain of DDI1, which binds to the Ufo1 protein, and the UBA domain, which binds ubiquitin chains on substrates (Voloshin2012Transfer). DDI1 also interacts with the 19S proteasome regulatory particle, specifically binding to the Rpn1 subunit, which aids in the delivery of ubiquitinated substrates to the proteasome (Voloshin2012Transfer).

In addition to its role in protein degradation, DDI1 interacts with SNARE proteins, such as v-SNARE (Snc1, Snc2) and t-SNARE (Sso1), inhibiting exocytosis by preventing the formation of the SNARE complex necessary for vesicle fusion (Fabijan2024Domains). The RVP domain of DDI1, which is structurally similar to aspartic proteases, may also play a role in protein-protein interactions, potentially forming dimers that could influence its activity (Trempe2016Structural). These interactions highlight DDI1's multifaceted role in protein turnover and cellular stress responses.


## References


[1. (Voloshin2012Transfer) Olga Voloshin, Anya Bakhrat, Sharon Herrmann, and Dina Raveh. Transfer of ho endonuclease and ufo1 to the proteasome by the ubl-uba shuttle protein, ddi1, analysed by complex formation in vitro. PLoS ONE, 7(7):e39210, July 2012. URL: http://dx.doi.org/10.1371/journal.pone.0039210, doi:10.1371/journal.pone.0039210. This article has 16 citations and is from a peer-reviewed journal.](https://doi.org/10.1371/journal.pone.0039210)

[2. (Fabijan2024Domains) Artur Fabijan, Bartosz Polis, Agnieszka Zawadzka-Fabijan, Izabela Korabiewska, Krzysztof Zakrzewski, Emilia Nowosławska, and Michał Chojnacki. Domains in action: understanding ddi1’s diverse functions in the ubiquitin-proteasome system. International Journal of Molecular Sciences, 25(7):4080, April 2024. URL: http://dx.doi.org/10.3390/ijms25074080, doi:10.3390/ijms25074080. This article has 0 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/ijms25074080)

[3. (Lehrbach2016Proteasome) Nicolas J Lehrbach and Gary Ruvkun. Proteasome dysfunction triggers activation of skn-1a/nrf1 by the aspartic protease ddi-1. eLife, August 2016. URL: http://dx.doi.org/10.7554/elife.17721, doi:10.7554/elife.17721. This article has 223 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.7554/elife.17721)

[4. (Elu2019Detailed) Nagore Elu, Nerea Osinalde, Javier Beaskoetxea, Juanma Ramirez, Benoit Lectez, Kerman Aloria, Jose Antonio Rodriguez, Jesus M. Arizmendi, and Ugo Mayor. Detailed dissection of ube3a-mediated ddi1 ubiquitination. Frontiers in Physiology, May 2019. URL: http://dx.doi.org/10.3389/fphys.2019.00534, doi:10.3389/fphys.2019.00534. This article has 16 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fphys.2019.00534)

[5. (Trempe2016Structural) Jean-François Trempe, Klára Grantz Šašková, Monika Sivá, Colin D. H. Ratcliffe, Václav Veverka, Annabelle Hoegl, Marie Ménade, Xin Feng, Solomon Shenker, Michal Svoboda, Milan Kožíšek, Jan Konvalinka, and Kalle Gehring. Structural studies of the yeast dna damage-inducible protein ddi1 reveal domain architecture of this eukaryotic protein family. Scientific Reports, September 2016. URL: http://dx.doi.org/10.1038/srep33671, doi:10.1038/srep33671. This article has 41 citations and is from a peer-reviewed journal.](https://doi.org/10.1038/srep33671)